[Indications and clinical application of thrombosis prophylaxis. I].
Mittelkötter
U
U
Chirurgische Universitätsklinik und Poliklinik, Universität Würzburg.
Reith
H B
HB
Thiede
A
A
D000925:Anticoagulants / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006496:Heparinoids / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control*; D012307:Risk Factors; D013923:Thromboembolism / Q000517:prevention & control; D013927:Thrombosis / Q000517:prevention & control*; D020246:Venous Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006493:Heparin